Enrollment trends and payer activity indicate that Medicare Advantage is a steady growth area for carriers in Missouri. While volatility and political uncertainty cloud other sectors of the health insurance market, Medicare Advantage is a reliable opportunity, and is expected to remain that way as an increasing number of baby boomers retire each year.


Related Reports

Systemic Lupus Erythematosus - Landscape & Forecast - Disease Landscape & Forecast

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course,...

View Details

Systemic Lupus Erythematosus | Disease Landscape and Forecast | G7 | 2020

Systemic lupus erythematosus (SLE) is a complex autoimmune disease that can affect nearly any organ or system in the body. As a result, its course, manifestations, and treatment approach can be hig...

View Details

Systemic Lupus Erythematosus - Current Treatment - Detailed, Expanded Analysis: Treatment Algorithms - Claims Data Analysis (US) 2021

MARKET OUTLOOK Systemic lupus erythematosus (SLE) is an autoimmune disease that affects multiple organ systems of the body. SLE symptoms range from general malaise to serio...

View Details

Systemic Lupus Erythematosus - Access & Reimbursement - Detailed, Expanded Analysis (US)

The systemic lupus erythematosus (SLE) therapy market in the United States is largely genericized and off-label. With the exception of GlaxoSmithKline’s Benlysta—which launched in 2011&...

View Details